Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MARKETS
La Jolla Stock Plummets 44% After Disappointing Drug Sales Projections
By Scott Van Voorhis
Jan 7, 2019 2:36 PM EST
PRESS RELEASES
Larry Edwards Appointed President And Chief Executive Officer Of La Jolla Pharmaceutical Company
By GlobeNewswire
Jul 28, 2020 4:16 PM EDT
PRESS RELEASES
La Jolla Pharmaceutical Company Announces The Closing Of Acquisition Of Tetraphase Pharmaceuticals, Inc.
By GlobeNewswire
Jul 28, 2020 4:15 PM EDT
PRESS RELEASES
La Jolla Pharmaceutical Company To Provide GIAPREZA™ (Angiotensin II) For Emergency Medical Program In Patients With Septic Shock Due To COVID-19 At CHIREC Delta Hospital, Brussels, Belgium
By GlobeNewswire
Apr 13, 2020 8:30 AM EDT
PRESS RELEASES
La Jolla Pharmaceutical Company To Provide GIAPREZA™ (Angiotensin II) For Named Patient Emergency Use In Patients With Septic Shock Due To COVID-19 At Royal Surrey County Hospital, Guildford, Surrey, United Kingdom
By GlobeNewswire
Apr 6, 2020 8:30 AM EDT
PRESS RELEASES
La Jolla Pharmaceutical Company To Provide GIAPREZA™ (Angiotensin II) For Named Patient Emergency Use In Patients With Septic Shock Due To COVID-19 At University Hospital Frankfurt In Germany
By GlobeNewswire
Apr 3, 2020 8:30 AM EDT
PRESS RELEASES
La Jolla Pharmaceutical Company To Provide GIAPREZA™ (Angiotensin II) For Named Patient Emergency Use In Patients With Septic Shock Due To COVID-19 At Guy's And St. Thomas' NHS Foundation Trust, London, United Kingdom
By GlobeNewswire
Apr 2, 2020 8:30 AM EDT
PRESS RELEASES
La Jolla Pharmaceutical Company To Provide GIAPREZA™ (Angiotensin II) In Italy For Compassionate Use In Patients With Septic Shock Associated With COVID-19
By GlobeNewswire
Mar 13, 2020 8:00 AM EDT
MARKETS
La Jolla Stock Plummets 44% After Disappointing Drug Sales Projections
By Scott Van Voorhis
Jan 7, 2019 2:36 PM EST
STOCKS
Mixed Outcomes for La Jolla Pharma Shock Drug Fuels Debate Over Sales Potential
By Adam Feuerstein
May 22, 2017 7:13 AM EDT
STOCKS
6 Hot Unusual Volume Setups
By Roberto Pedone
May 19, 2017 7:00 AM EDT
VIDEO
6 Stocks with Unusual Volume Activity
By TheStreet Staff
Feb 28, 2017 10:46 AM EST
STOCKS
6 Stocks on the Move With Unusual Volume
By Roberto Pedone
Feb 28, 2017 10:40 AM EST
FUTURES
Stocks inch higher in cautious trading ahead of Trump's budget, tax plans
By Keris Alison Lahiff
Feb 27, 2017 1:59 PM EST
STOCKS
How to trade Monday's most active stocks: AMD, La Jolla Pharma, Tesla and more
By Jonas Elmerraji
Feb 27, 2017 12:29 PM EST
FUTURES
Stocks trade flat as Trump pledges $54b bump in defense spending
By Keris Alison Lahiff
Feb 27, 2017 11:24 AM EST
VIDEO
What You Need to Know About La Jolla's Shock-Treatment Drug
By TheStreet Staff
Feb 27, 2017 9:12 AM EST
FUTURES
Stock futures retreat as Wall Street awaits details of Trump's tax plan
By Keris Alison Lahiff
Feb 27, 2017 8:38 AM EST
STOCKS
La Jolla Pharma drug raises blood pressure in late-stage study of shock patients
By Adam Feuerstein
Feb 27, 2017 8:10 AM EST
STOCKS
La Jolla Pharmaceutical Spikes on Positive Trial Results
By Tony Owusu
Feb 27, 2017 7:44 AM EST
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: These 5 Are Falling for Holding Too Much Cash
By Scott Rutt
May 23, 2016 8:25 PM EDT
MARKETS
La Jolla Pharmaceutical (LJPC) Weak On High Volume Today
By TheStreet Wire
Nov 20, 2015 10:22 AM EST
JIM CRAMER
'Mad Money' Lightning Round: Take PPG Over Sherwin-Williams
By Scott Rutt
Sep 29, 2015 6:00 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: 5 Groups You Once Loved but Now Hate
By Scott Rutt
Sep 28, 2015 8:15 PM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
By Chris Sahl
Aug 4, 2015 8:40 PM EDT
